Co-Diagnostics Inc. (CODX)

2.25 -0.01 (-0.442%)

IEX Real-Time Price

November 16, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 2.26

Price Open 2.25

Volume: 22,867

Avg Volume: 12,716

Market Cap: 27.78M

P/E Ratio -

52 Wk Range 1.45-6.66



CODX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
10.07M
82,625
5.09
0.82%

2018-09-28
10.07M
102,298
4.62
1.02%

2018-09-14
10.07M
104,849
3.70
1.04%

2018-08-31
10.07M
116,572
4.62
1.16%




News

Co-Diagnostics, Inc. and LGC, Biosearch Technologies Sign License Agreement for CoPrimer Technology (2018-10-30 06:30 Business Wire)

Co-Diagnostics agrees to license CoPrimers for use in agricultural applications Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, and LGC, Biosearch Technologies, a gl…

 


Statistics

Shares Outstanding: 12.35M

Top 15 Institution Percent: 1.70

Price To Sales: 1392.59

Price To Book: 31.59

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -663.18

Return On Equity: 512.71

Profit Margin: N/A

Price History

Beta: 1.54

50-day Moving Avg: 2.52

200-day Moving Avg: 2.77

YTD Change: -18.12

5-day Change: -2.16

1-month Change: -7.05

3-month Change: -32.94

6-month Change: 26.62

1-year Change: -56.29

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Co-Diagnostics Inc.

Exchange: NASDAQ Capital Market

Industry: Medical Diagnostics & Research

Sector: Healthcare

Website: http://www.codiagnostics.com

Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.